16
Table 11. Recommendations for Treatment of Stage B HF
Recommendations COR LOE
In patients with a history of MI and reduced EF, ACE inhibitors
or ARBs should be used to prevent HF
I A
In patients with MI and reduced EF, evidence-based beta blockers
should be used to prevent HF
I B
In patients with MI, statins should be used to prevent HF I A
Blood pressure should be controlled to prevent symptomatic HF I A
ACE inhibitors should be used in all patients with a reduced EF
to prevent HF
I A
Beta blockers should be used in all patients with a reduced EF to
prevent HF
I C
An ICD is reasonable in patients with asymptomatic ischemic
cardiomyopathy who are ≥40 days post-MI, have an LVEF ≤30%,
and are on GDMT
IIa B
Nondihydropyridine calcium channel blockers may be harmful in
patients with low LVEF
III:
Harm
C
Treatment
